Skip to content
Screener

Health Catalyst HCAT Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$80.7MMiss by $4.4M
EPS$0.04Beat by $0.01
Revenue estimate$85.1M
EPS estimate$0.03

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$55.4M
EPS estimate-$0.02

Financials

Q2 2025

Income statement

See full
Revenue$80.7M+6.3%
Gross profit$38.2M+6.7%
Operating income-$37.1M-135%
Net income-$41.0M-203%
EPS (diluted)-$0.59-157%

Balance sheet

See full
Cash & equivalents$50.7M-74.9%
Total debt$172.8M+769%
Total equity$347.5M-2.6%
Total assets$616.2M-10.9%

Cash flow

See full
Operating cash flow-$9.0M-658%
Free cash flow-$8.8M-763%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$260.66M-30.9%
Enterprise value$382.73M+96.1%
P/S0.8×-0.4×

Profitability

See full
Gross margin45.3%+0.4pp
Operating margin-28%-3.2pp
Net margin-31.7%+3.4pp

Returns & leverage

See full
Return on equity-28.4%+8.4pp
Debt / equity0.5×+0.4×
Current ratio1.8×+0.6×

Segments

By product

See full
Recurring technology$52.9M—
Technology$52.9M+11.0%
Accumulated Impairment Losses$27.8M-1.5%

By segment

See full
Technology$52.9M+11.0%
Accumulated Impairment Losses$27.8M-1.5%

FAQ

When did Health Catalyst report Q2 2025 earnings?
Health Catalyst (HCAT) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Health Catalyst's Q2 2025 revenue and EPS?
Health Catalyst reported revenue of $80.7M and eps of $0.04 for Q2 2025.
Did Health Catalyst beat estimates in Q2 2025?
Revenue missed the consensus estimate of $85.1M by $4.4M. EPS beat the consensus estimate of $0.03 by $0.01.
How did Health Catalyst's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.3% from $75.9M a year earlier and eps declined 66.7% from $0.12.
Where can I find Health Catalyst's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001636422-25-000108) and the 10-Q periodic report (0001636422-25-000111) directly on SEC EDGAR. The filing index links above go to sec.gov.